These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4541583)

  • 1. Standardization of tetanus toxoid combined with pertussis vaccine. II. Some considerations on the standard toxoid for the assay of combined vaccine.
    Yamamoto A; Kondo S; Sadahiro S; Murata R
    Jpn J Med Sci Biol; 1972 Aug; 25(4):281-5. PubMed ID: 4541583
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 3. Standardization of tetanus toxoid combined with pertussis vaccine.
    Murata R; Someya S; Kaneko J
    Jpn J Med Sci Biol; 1970 Jun; 23(3):211-6. PubMed ID: 5311751
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization and control of toxoid components in the combined vaccine (DPT).
    Kondo S; Kameyama S; Murata R
    Jpn J Med Sci Biol; 1974 Dec; 27(6):315-9. PubMed ID: 4466849
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z; Zsidai J
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PREPARATION OF THE REFERENCE DIPHTHERIA-TETANUS-PERTUSSIS VACCINE AND STARDARDIZATION OF ITS DIPHTHERIA AND TETANUS COMPONENTS. I. THE DIPHTHERIA COMPONENT].
    GALAZKA A
    Med Dosw Mikrobiol; 1964; 16():295-308. PubMed ID: 14313908
    [No Abstract]   [Full Text] [Related]  

  • 8. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 9. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
    Van Ramshorst JD; Sundaresan TK; Outschoorn AS
    Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PREPARATION OF THE REFERENCE DIPHTHERIA-TETANUS-PERTUSSIS VACCINE AND STANDARDIZATION OF ITS DIPHTHERIA AND TETANUS COMPONENTS. II. THE TETANUS COMPONENT].
    GALAZKA A
    Med Dosw Mikrobiol; 1964; 16():309-21. PubMed ID: 14313909
    [No Abstract]   [Full Text] [Related]  

  • 11. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory testing of combined diphtheria-tetanus-pertussis-typhoid vaccines.
    Csizér Z; Joó I; Réthy L; Juhász VP
    Prog Immunobiol Stand; 1971; 5():394-8. PubMed ID: 4660543
    [No Abstract]   [Full Text] [Related]  

  • 13. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 14. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the epinephrine-refractory hypoglycaemic activity of whole-cell pertussis vaccine in mice.
    Horiuchi Y; Iida T
    J Biol Stand; 1988 Oct; 16(4):239-48. PubMed ID: 3143732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [OBSERVATIONS ON THE RELATIONSHIP BETWEEN IMMUNOLOGICAL RESPONSES OF THE ANIMAL ORGANISM TO ANTIGENS CONTAINED IN DIPHTHERIA-TETANUS-WHOOPING COUGH VACCINES].
    SEMBRAT-NIEWIADOMSKA Z; HOLCER Z; TUROWSKI G
    Med Dosw Mikrobiol; 1964; 16():101-10. PubMed ID: 14203986
    [No Abstract]   [Full Text] [Related]  

  • 19. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [STATISTICO-CLINICAL DATA ON THE USE OF THE COMBINED DIPHTHERIA-PERTUSSIS-TETANUS-POLIOVIRUS VACCINE IN INFANTS].
    GIURANNA U
    Pediatria (Napoli); 1963; 71():962-7. PubMed ID: 14125501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.